Re: V. Usonis et al.: Comparative study of reactogenicity and immunogenicity of new and established measles, mumps and rubella vaccines in healthy children (Infection 26 [1998] 222-226)
Nalin
D
D
D002648:Child; D002986:Clinical Trials as Topic / Q000592:standards; D015986:Confounding Factors, Epidemiologic; D006801:Humans; D008458:Measles Vaccine / Q000009:adverse effects* / Q000276:immunology*; D022542:Measles-Mumps-Rubella Vaccine; D009108:Mumps Vaccine / Q000009:adverse effects* / Q000276:immunology*; D012411:Rubella Vaccine / Q000009:adverse effects* / Q000276:immunology*; D016037:Single-Blind Method; D017778:Vaccines, Combined / Q000009:adverse effects / Q000276:immunology
D008458:Measles Vaccine; D022542:Measles-Mumps-Rubella Vaccine; D009108:Mumps Vaccine; D012411:Rubella Vaccine; D017778:Vaccines, Combined